A detailed history of Creative Planning transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Creative Planning holds 4,672 shares of CRL stock, worth $904,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,672
Previous 4,492 4.01%
Holding current value
$904,265
Previous $927,000 0.76%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$187.96 - $245.29 $33,832 - $44,152
180 Added 4.01%
4,672 $920,000
Q2 2024

Aug 15, 2024

SELL
$206.39 - $268.73 $7,842 - $10,211
-38 Reduced 0.84%
4,492 $927,000
Q1 2024

May 10, 2024

BUY
$203.52 - $273.43 $62,887 - $84,489
309 Added 7.32%
4,530 $1.23 Million
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $77,817 - $112,971
-473 Reduced 10.08%
4,221 $997,000
Q3 2023

Nov 16, 2023

BUY
$194.44 - $217.61 $269,688 - $301,825
1,387 Added 41.94%
4,694 $919,000
Q2 2023

Jul 21, 2023

BUY
$183.71 - $210.25 $13,778 - $15,768
75 Added 2.32%
3,307 $695,000
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $78,483 - $106,307
-409 Reduced 11.23%
3,232 $652,000
Q4 2022

Feb 10, 2023

BUY
$197.11 - $250.07 $7,884 - $10,002
40 Added 1.11%
3,641 $793,000
Q3 2022

Nov 03, 2022

BUY
$182.44 - $250.54 $107,092 - $147,066
587 Added 19.48%
3,601 $709,000
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $24,699 - $36,590
121 Added 4.18%
3,014 $645,000
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $133,376 - $189,021
522 Added 22.02%
2,893 $821,000
Q4 2021

Feb 11, 2022

BUY
$351.38 - $448.68 $48,139 - $61,469
137 Added 6.13%
2,371 $893,000
Q3 2021

Nov 10, 2021

BUY
$372.64 - $458.3 $11,179 - $13,749
30 Added 1.36%
2,234 $922,000
Q2 2021

Aug 04, 2021

SELL
$294.17 - $371.65 $91,781 - $115,954
-312 Reduced 12.4%
2,204 $815,000
Q1 2021

Apr 30, 2021

BUY
$249.67 - $299.48 $42,693 - $51,211
171 Added 7.29%
2,516 $729,000
Q4 2020

Jan 29, 2021

SELL
$222.0 - $252.62 $14,874 - $16,925
-67 Reduced 2.78%
2,345 $586,000
Q3 2020

Nov 05, 2020

BUY
$175.56 - $226.45 $18,960 - $24,456
108 Added 4.69%
2,412 $546,000
Q1 2020

May 05, 2020

BUY
$98.9 - $178.34 $593 - $1,070
6 Added 0.26%
2,304 $291,000
Q4 2019

Jan 30, 2020

SELL
$126.05 - $152.76 $5,420 - $6,568
-43 Reduced 1.84%
2,298 $351,000
Q3 2019

Nov 01, 2019

SELL
$125.07 - $143.67 $2,376 - $2,729
-19 Reduced 0.81%
2,341 $310,000
Q2 2019

Jul 26, 2019

BUY
$123.4 - $148.55 $3,208 - $3,862
26 Added 1.11%
2,360 $335,000
Q1 2019

Apr 24, 2019

SELL
$104.82 - $146.73 $524 - $733
-5 Reduced 0.21%
2,334 $339,000
Q4 2018

Feb 01, 2019

BUY
$105.09 - $137.23 $52,650 - $68,752
501 Added 27.26%
2,339 $265,000
Q3 2018

Oct 25, 2018

SELL
$112.11 - $134.54 $20,179 - $24,217
-180 Reduced 8.92%
1,838 $247,000
Q2 2018

Jul 20, 2018

BUY
$102.37 - $117.25 $12,898 - $14,773
126 Added 6.66%
2,018 $227,000
Q1 2018

Apr 18, 2018

BUY
$98.19 - $115.2 $5,989 - $7,027
61 Added 3.33%
1,892 $202,000
Q4 2017

Jan 17, 2018

SELL
$100.43 - $118.09 $21,692 - $25,507
-216 Reduced 10.55%
1,831 $200,000
Q3 2017

Oct 17, 2017

BUY
$96.72 - $109.26 $197,985 - $223,655
2,047
2,047 $221,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.84B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.